ADUS
Get informed when a big investor buys or sells
+ FollowUndervalued by 80.7% based on the discounted cash flow analysis.
| Market cap | $2.02 Billion |
|---|---|
| Enterprise Value | $2.06 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.19 |
| Beta | 0.88 |
| Outstanding Shares | 18,486,000 |
| P/E Ratio | 20 |
|---|---|
| PEG | 110.54 |
| Price to Sales | 1.39 |
| Price to Book Ratio | 1.81 |
| Enterprise Value to Revenue | 1.42 |
| Enterprise Value to EBIT | 14.51 |
| Enterprise Value to Net Income | 20 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.12 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 3.78%▼ 100.58% |
|---|---|
| Total Invested | $70.20M▼ 96.11% |
| Investors Holding | 12▼ 288.00% |
No data
Jurisdiction over Medicare and Medicaid, which provide the vast majority of Addus's revenue; directly controls reimbursement rates.
Authorizes the specific dollar amounts for health programs; determines the actual cash flow into the state and federal programs Addus bills.
Regulates labor laws and caregiver standards; labor costs and nursing regulations are critical drivers of Addus's profitability.
Directly investigates long-term care and home-based services; hearings create significant headline risk and regulatory pressure for Addus.